Respiratory Care Devices Market Growth Analysis, Emerging Trends, Opportunities, Sales Revenue,COVID 19 Analysis, Business Strategy, Future Prospects and Industry Outlook 2028

Global Respiratory Care Devices Market Overview
The global respiratory care devices market is anticipated to grow at a rate of approximately 7–8% by 2028, driven by rising respiratory disease prevalence, the expanding elderly population, rapid urbanization, increasing tobacco consumption, and significant technological progress in respiratory management tools.

Year-End Mega Sale: Get Up to 10% Off on All Market Research Reports!

As respiratory disorders become more common worldwide, the demand for advanced, accurate, and user-friendly respiratory care devices continues to escalate across hospitals, clinics, and home-care settings.
Respiratory care devices play a vital role in diagnosing, monitoring, and treating a wide spectrum of respiratory issues. These medical technologies support clinical decision-making and patient care for conditions such as asthma, COPD, sleep apnea, pneumonia, and various acute and chronic respiratory disorders. Their importance has increased significantly in recent years as healthcare systems prioritize early diagnosis, continuous monitoring, and accessible treatment solutions.
Types of Respiratory Care Devices
Diagnostic and Monitoring Devices: These tools evaluate lung performance, help detect abnormalities, and support ongoing monitoring. Examples include spirometers, peak flow meters, and pulse oximeters.
Airway Devices: Designed to keep the airway open and ensure adequate oxygen flow. Common devices include endotracheal tubes and laryngeal mask airways (LMAs).
Nebulizers: These systems convert liquid medications into aerosolized particles, making them easier to inhale for conditions like asthma or cystic fibrosis.
Positive Expiratory Pressure (PEP) Devices: These devices help facilitate mucus clearance by generating resistance during exhalation.
Ventilators: Mechanical ventilators assist patients with severe respiratory insufficiency or failure by supporting or fully taking over the breathing process.
Rising Prevalence of COPD as a Key Market Driver
Chronic Obstructive Pulmonary Disease (COPD) remains one of the most severe and widespread respiratory illnesses, characterized by irreversible airflow limitation, chronic inflammation, and damage to lung tissue. According to the World Health Organization (WHO), COPD is the third leading cause of death globally, with approximately 480 million people affected. Furthermore, a study published by the Journal of the American Medical Association (JAMA) predicts that COPD prevalence among individuals aged 25 and above will rise by 23% between 2020 and 2050, with a pronounced increase among women and populations in low- and middle-income countries.
While COPD is progressive, early detection and comprehensive management can significantly lessen symptoms, enhance quality of life, and reduce complications. New technologies are emerging to support earlier and more accurate diagnosis. For example, in August 2023, TidalSense introduced a regulated AI-powered COPD assessment tool utilizing the N-Tidal device and integrated AI algorithms to detect subtle changes in lung function within minutes. Such advancements reflect the growing emphasis on innovation to combat rising COPD cases.
Technological Advancements Fueling Market Expansion
Innovations in respiratory care technology are reshaping how chronic respiratory diseases are managed. Connected devices, artificial intelligence, and compact digital health tools are helping patients and clinicians monitor conditions more accurately and intervene earlier. These advancements improve adherence, reduce emergency events, and contribute to personalized care delivery. Some notable developments include:
Smart Inhalers: Equipped with sensors and connectivity features, these inhalers track medication usage and improve adherence while providing clinicians with valuable patient data. They enable targeted treatment for asthma and COPD by delivering bronchodilators directly into the airways.
Advanced Algorithms: AI-driven tools can analyze imaging such as chest X-rays to detect respiratory abnormalities earlier, facilitating faster and more precise diagnosis.
Wearable Devices: Compact and portable solutions such as mini ventilators, wearable respiratory monitors, and portable nebulizers enhance patient mobility and convenience.
Telehealth Solutions: Remote monitoring platforms enable virtual consultations and continuous surveillance for individuals with chronic respiratory conditions, reducing hospital visits and supporting timely clinical intervention.
Non-Invasive Ventilation (NIV) Devices: Improvements in CPAP and BiPAP systems—particularly in comfort, design, and data connectivity—are boosting patient acceptance and long-term therapy adherence.
Impact of Covid-19 on the Respiratory Care Devices Market
The Covid-19 pandemic dramatically accelerated the demand for respiratory support equipment. A global surge in cases created unprecedented requirements for ventilators, oxygen concentrators, pulse oximeters, PAP devices, and spirometers. This period highlighted the critical role of respiratory devices in emergency care and strengthened the focus on home-based respiratory support solutions.
With hospitals overwhelmed, many patients relied on home oxygen systems, portable ventilators, and CPAP devices to manage symptoms and prevent deterioration. The heightened vulnerability of individuals with bronchitis, COPD, and other respiratory issues further intensified demand. Although pandemic-driven spikes were temporary, they significantly expanded awareness and adoption of respiratory care technologies.
Regional Insights
North America currently holds a dominant share in the global respiratory care devices market. Factors contributing to this leadership include higher disease prevalence, strong adoption of technologically advanced solutions, lifestyle-related risk factors such as smoking and sedentary habits, and well-established healthcare infrastructure.
Meanwhile, the Asia-Pacific region is expected to witness the fastest growth over the coming years. This rise is attributed to rapid urbanization, worsening air quality, large patient populations, increasing innovation in medical devices, and expanding healthcare access across emerging economies.
Competitive Landscape
Some of the prominent companies operating in the respiratory care devices market include:
• GE Healthcare
• Philips Respironics (Philips Healthcare)
• Masimo Corporation
• Hamilton Medical
• Smiths Medical
• TidalSense
• Vyaire Medical
• Devilbiss Healthcare LLC
• Medtronic PLC
• Drägerwerk AG & Co. KGaA
• Fisher & Paykel Healthcare Limited
• ResMed Inc.
Organic and Inorganic Growth Strategies
Companies in this market are actively adopting strategies such as new product launches, acquisitions, and collaborations to strengthen their market position and broaden product portfolios.
In June 2023, Avanos Medical, Inc. entered an agreement to sell its Respiratory Health business to SunMed Group Holdings, enhancing SunMed's presence in respiratory care.
In March 2023, Vitalograph launched the VitaloPFT Pulmonary Function Testing Series, targeted for secondary care environments.
Looking ahead, the respiratory care devices market is poised for sustained growth. Increasing device approvals, a stronger focus on managing prevalent respiratory diseases, and continued expansion through strategic partnerships and innovation will shape the sector's future.

Download pdf Brochure: https://meditechinsights.com/respiratory-care-devices-market/request-sample/

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.